Bb Biotech as of Dec. 31, 2018
Portfolio Holdings for Bb Biotech
Bb Biotech holds 34 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals (IONS) | 15.1 | $473M | 8.7M | 54.06 | |
| Incyte Corporation (INCY) | 7.8 | $242M | 3.8M | 63.59 | |
| Neurocrine Biosciences (NBIX) | 7.7 | $239M | 3.3M | 71.41 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 7.3 | $227M | 1.4M | 165.71 | |
| Esperion Therapeutics (ESPR) | 5.0 | $156M | 3.4M | 46.00 | |
| Celgene Corporation | 4.7 | $148M | 2.3M | 64.09 | |
| Agios Pharmaceuticals (AGIO) | 4.2 | $133M | 2.9M | 46.11 | |
| Sage Therapeutics (SAGE) | 4.2 | $132M | 1.4M | 95.79 | |
| Alexion Pharmaceuticals | 4.1 | $128M | 1.3M | 97.36 | |
| Halozyme Therapeutics (HALO) | 3.9 | $122M | 8.3M | 14.63 | |
| Alnylam Pharmaceuticals (ALNY) | 3.7 | $115M | 1.6M | 72.91 | |
| Radius Health | 3.5 | $111M | 6.7M | 16.49 | |
| Argenx Se (ARGX) | 2.7 | $85M | 885k | 96.07 | |
| Gilead Sciences (GILD) | 2.7 | $83M | 1.3M | 62.55 | |
| Moderna (MRNA) | 2.3 | $73M | 4.8M | 15.27 | |
| Akcea Therapeutics Inc equities | 2.3 | $72M | 2.4M | 30.14 | |
| Wave Life Sciences (WVE) | 2.0 | $62M | 1.5M | 42.04 | |
| Myovant Sciences | 1.9 | $59M | 3.6M | 16.41 | |
| Intercept Pharmaceuticals In | 1.9 | $58M | 576k | 100.79 | |
| Exelixis (EXEL) | 1.8 | $56M | 2.8M | 19.67 | |
| Nektar Therapeutics (NKTR) | 1.4 | $45M | 1.4M | 32.87 | |
| Myokardia | 1.4 | $43M | 877k | 48.86 | |
| Macrogenics (MGNX) | 1.3 | $42M | 3.3M | 12.70 | |
| Scholar Rock Hldg Corp (SRRK) | 0.9 | $29M | 1.3M | 22.97 | |
| Alder Biopharmaceuticals | 0.9 | $28M | 2.8M | 10.25 | |
| Voyager Therapeutics (VYGR) | 0.9 | $27M | 2.9M | 9.40 | |
| Regeneron Pharmaceuticals (REGN) | 0.8 | $26M | 68k | 373.50 | |
| Intra Cellular Therapies (ITCI) | 0.8 | $25M | 2.2M | 11.39 | |
| Kezar Life Sciences (KZR) | 0.6 | $19M | 818k | 23.60 | |
| Audentes Therapeutics | 0.5 | $16M | 769k | 21.32 | |
| Sangamo Biosciences (SGMO) | 0.5 | $16M | 1.4M | 11.48 | |
| Novavax | 0.5 | $15M | 8.3M | 1.84 | |
| G1 Therapeutics (GTHX) | 0.4 | $13M | 672k | 19.15 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.2 | $5.4M | 2.3M | 2.35 |
